Patents Assigned to Transition Therapeutics (Ireland 2) Limited
  • TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BHP
    Publication number: 20180185347
    Abstract: Methods of treating the signs and symptoms of Benign Prostatic Hyperplasia (BPH) in a subject by administering at least one tetrahydrocyclopenta[b]indole compound are disclosed. Also disclosed are methods of treating the signs and symptoms of BPH in a subject by administering at least one tetrahydrocyclopenta[b]indole compound in combination with a phosphodiesterase type-5 inhibitor.
    Type: Application
    Filed: November 15, 2017
    Publication date: July 5, 2018
    Applicant: Transition Therapeutics (Ireland 2) Limited
    Inventors: Antonio F. CRUZ, Phillip FROST